• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于监测、流行病学与最终结果(SEER)数据库的早期(pT1-2N0M0)舌鳞状细胞癌预后列线图及术后放疗的观察性分析

A SEER-based prognostic nomogram for early-stage (pT1-2N0M0) tongue squamous cell carcinoma and an observational analysis of postoperative radiotherapy.

作者信息

Lin Dandan, Li Huling, Feng Xing, Zhang Yang, Tang Dandan, Wang Kai

机构信息

School of Public Health, Xinjiang Medical University, Urumqi, China.

College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, China.

出版信息

World J Surg Oncol. 2025 Jul 25;23(1):302. doi: 10.1186/s12957-025-03883-2.

DOI:10.1186/s12957-025-03883-2
PMID:40713628
Abstract

BACKGROUND

To develop a nomogram for predicting overall survival (OS) and cancer-specific survival (CSS) in patients with postoperative early-stage (pT1-2N0M0) tongue squamous cell carcinoma (TSCC), and to explore the association between postoperative radiotherapy (PORT) and patient survival.

METHODS

Data from 7,637 patients with pT1-2N0M0 TSCC who underwent surgery between 2000 and 2021 were extracted from the SEER database. Patients were randomly divided into a training cohort and a validation cohort in a 2:1 ratio. Prognostic factors were identified via Kaplan-Meier analysis and Cox regression, and a nomogram was constructed. To minimize confounding, propensity score matching (PSM) was used to compare outcomes between patients who received PORT and those who did not. Subgroup and interaction analyses were performed to assess potential effect modifiers.

RESULTS

Of the 7,637 patients included, 1,336 (17.5%) received PORT. Multivariate Cox analysis identified age, race, marital status, grade, tumor size, lymph node (LN) removed status, and PORT as independent prognostic factors for OS and CSS. The nomogram demonstrated strong predictive performance based on time-dependent ROC curves, concordance indices, calibration plots, and decision curve analyses in both training and validation cohorts. After PSM, PORT remained associated with worse OS and CSS. Subgroup analyses revealed that the association between PORT and poorer OS was most evident in younger patients, married individuals, T1 stage patients, those with smaller tumors, and those without LN removal, with racial disparities also observed. For CSS, this association was more pronounced in married individuals, well-differentiated patients, T1 stage patients, those with smaller tumors, and those without LN removal.

CONCLUSION

The SEER-based nomogram provides survival predictions for postoperative pT1-2N0M0 TSCC patients. Although PORT was associated with worse survival in several subgroups, findings should be cautiously interpreted given the observational design and absence of key clinical variables (PNI, LVI, surgical margins). Prospective studies incorporating comprehensive clinicopathological data are warranted to confirm associations and guide individualized PORT decisions in early-stage TSCC patients.

摘要

背景

建立一种列线图,用于预测术后早期(pT1-2N0M0)舌鳞状细胞癌(TSCC)患者的总生存期(OS)和癌症特异性生存期(CSS),并探讨术后放疗(PORT)与患者生存之间的关联。

方法

从监测、流行病学和最终结果(SEER)数据库中提取2000年至2021年间接受手术的7637例pT1-2N0M0 TSCC患者的数据。患者按2:1的比例随机分为训练队列和验证队列。通过Kaplan-Meier分析和Cox回归确定预后因素,并构建列线图。为了尽量减少混杂因素,采用倾向评分匹配(PSM)来比较接受PORT的患者和未接受PORT的患者的结局。进行亚组分析和交互分析以评估潜在的效应修饰因素。

结果

在纳入的7637例患者中,1336例(17.5%)接受了PORT。多因素Cox分析确定年龄、种族、婚姻状况、分级、肿瘤大小、淋巴结(LN)切除状态和PORT是OS和CSS的独立预后因素。列线图在训练队列和验证队列中基于时间依赖性ROC曲线、一致性指数、校准图和决策曲线分析显示出强大的预测性能。PSM后,PORT仍然与较差的OS和CSS相关。亚组分析显示,PORT与较差OS之间的关联在年轻患者、已婚个体、T1期患者、肿瘤较小的患者以及未切除LN的患者中最为明显,也观察到种族差异。对于CSS,这种关联在已婚个体、高分化患者、T1期患者中更为明显。肿瘤较小的患者以及未切除LN的患者。

结论

基于SEER的列线图为术后pT1-2N0M0 TSCC患者提供生存预测。尽管PORT在几个亚组中与较差的生存相关,但鉴于观察性设计和关键临床变量(PNI、LVI、手术切缘)的缺乏,研究结果应谨慎解释。有必要进行纳入全面临床病理数据的前瞻性研究,以证实关联并指导早期TSCC患者的个体化PORT决策。

相似文献

1
A SEER-based prognostic nomogram for early-stage (pT1-2N0M0) tongue squamous cell carcinoma and an observational analysis of postoperative radiotherapy.基于监测、流行病学与最终结果(SEER)数据库的早期(pT1-2N0M0)舌鳞状细胞癌预后列线图及术后放疗的观察性分析
World J Surg Oncol. 2025 Jul 25;23(1):302. doi: 10.1186/s12957-025-03883-2.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.基于 2019 年 WHO 分类的胰腺实性假乳头状瘤患者临床特征、预后因素和生存的综合研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12393-12404. doi: 10.1007/s00432-023-04982-x. Epub 2023 Jul 13.
4
Development and validation of nomograms for predicting survival of locally advanced rectosigmoid junction cancer patients: a SEER database analysis.预测局部晚期直肠乙状结肠交界处癌患者生存的列线图的开发与验证:一项监测、流行病学和最终结果(SEER)数据库分析
Transl Cancer Res. 2025 May 30;14(5):2808-2821. doi: 10.21037/tcr-24-1810. Epub 2025 May 27.
5
Identification of Patients with Early-Stage Hepatocellular Carcinoma Benefiting from Neoadjuvant Chemotherapy-A SEER-Based Study.基于监测、流行病学和最终结果(SEER)数据库研究:识别从新辅助化疗中获益的早期肝细胞癌患者
J Gastrointest Cancer. 2025 Jun 29;56(1):144. doi: 10.1007/s12029-025-01264-2.
6
Survival benefit of postoperative chemotherapy in stage III lung squamous cell carcinoma based on SEER database analysis through propensity score matching.基于监测、流行病学和最终结果(SEER)数据库分析及倾向评分匹配的Ⅲ期肺鳞状细胞癌术后化疗的生存获益
Sci Rep. 2025 Jul 1;15(1):22210. doi: 10.1038/s41598-025-07766-0.
7
A novel nomogram for survival prediction in renal cell carcinoma patients with brain metastases: an analysis of the SEER database.一种用于预测肾细胞癌脑转移患者生存情况的新型列线图:基于监测、流行病学和最终结果(SEER)数据库的分析
Front Immunol. 2025 Jun 30;16:1572580. doi: 10.3389/fimmu.2025.1572580. eCollection 2025.
8
Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.用于预测非转移性鼻咽癌生存结局并指导治疗的两个基于网络的动态交互式列线图和风险分层系统。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15969-15987. doi: 10.1007/s00432-023-05363-0. Epub 2023 Sep 8.
9
Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.提高预后准确性:基于 SEER 的分析用于预测宫颈腺癌患者的总体和癌症特异性生存。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17027-17037. doi: 10.1007/s00432-023-05399-2. Epub 2023 Sep 25.
10
A Nomogram for Predicting Cancer-Specific Survival in Patients With Stage I Vulvar Squamous Cell Carcinoma: A Study Based on the SEER Database and External Validation.预测Ⅰ期外阴鳞状细胞癌患者癌症特异性生存的列线图:一项基于监测、流行病学和最终结果(SEER)数据库及外部验证的研究
Cancer Control. 2025 Jan-Dec;32:10732748251357144. doi: 10.1177/10732748251357144. Epub 2025 Jul 2.

本文引用的文献

1
Histopathologic predictors of recurrence and survival in early T stage oral tongue squamous cell carcinoma.早期T分期舌癌复发及生存的组织病理学预测指标
Front Oral Health. 2024 Aug 6;5:1426709. doi: 10.3389/froh.2024.1426709. eCollection 2024.
2
Comparison of survival between palliative surgery and no surgery for advanced tongue squamous cell carcinoma: an analysis of SEER data.晚期舌鳞状细胞癌姑息性手术与非手术治疗的生存比较:基于监测、流行病学和最终结果(SEER)数据的分析
Int J Oral Maxillofac Surg. 2025 Jan;54(1):12-22. doi: 10.1016/j.ijom.2024.07.001. Epub 2024 Jul 17.
3
Occupation and tongue cancer in Nordic countries.
职业与北欧国家的舌癌。
BMC Oral Health. 2024 Apr 29;24(1):506. doi: 10.1186/s12903-024-04172-2.
4
Impact of Postoperative Radiotherapy on the Prognosis of Early-Stage (pT1-2N0M0) Oral Tongue Squamous Cell Carcinoma.术后放疗对早期(pT1-2N0M0)口腔舌鳞状细胞癌预后的影响。
J Clin Oncol. 2024 May 20;42(15):1754-1765. doi: 10.1200/JCO.23.01106. Epub 2024 Apr 1.
5
Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1-2N0-1M0: A retrospective analysis.T1-2N0-1M0 期手术治疗的舌鳞癌预后因素:回顾性分析。
Cancer Med. 2024 Feb;13(3):e7016. doi: 10.1002/cam4.7016.
6
Prognostic nomogram for patients with tongue squamous cell carcinoma: A SEER-based study.舌鳞状细胞癌患者的预后列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Oral Dis. 2024 Mar;30(2):292-306. doi: 10.1111/odi.14521. Epub 2023 Feb 13.
7
The Impact of Post-Operative Radiotherapy in Early Stage (pT1-pT2N0M0) Oral Tongue Squamous Cell Carcinoma in Era of DOI.DOI时代早期(pT1-pT2N0M0)口腔舌鳞状细胞癌术后放疗的影响
Cancers (Basel). 2021 Sep 28;13(19):4851. doi: 10.3390/cancers13194851.
8
Oral Cancer Screening: Past, Present, and Future.口腔癌筛查:过去、现在和未来。
J Dent Res. 2021 Nov;100(12):1313-1320. doi: 10.1177/00220345211014795. Epub 2021 May 26.
9
A New Nomogram for Predicting Overall Survival and Assisting Postoperative Adjuvant Treatment Decision-Making in Stage II Oral Tongue Squamous Cell Carcinoma: A Surveillance, Epidemiology and End Results (SEER) Database Analysis.一种预测II期口腔舌鳞状细胞癌总生存期并辅助术后辅助治疗决策的新列线图:监测、流行病学和最终结果(SEER)数据库分析
J Oral Maxillofac Surg. 2021 Oct;79(10):2147-2154. doi: 10.1016/j.joms.2021.04.010. Epub 2021 Apr 17.
10
Epidemiology of tongue squamous cell carcinoma: A retrospective cohort study.舌鳞状细胞癌的流行病学:一项回顾性队列研究。
Oral Dis. 2023 Mar;29(2):402-410. doi: 10.1111/odi.13897. Epub 2021 May 19.